Biomarkers, Risk Assessment, Imaging, and Neurodegeneration in Cerebral Small Vessel Disease (BRAIN-CSVD)

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorZhejiang Hospital

About this trial

The BRAIN-CSVD study is a single-center prospective cohort study focusing on cerebral small vessel disease (CSVD).Patients enrolled in this research will undergo assessments for vascular risk factors, cognitive and other neurological functions, neuroimaging, and biomarkers. The study aims to explore imaging and biomarker predictors of CSVD progression, and the pathophysiological mechanisms of CSVD.

Eligibility criteria

Qualifiers

Age >= 18 years old;

Cerebral small vessel disease on MR imaging.

Disqualifiers

Cerebral infarction (except lacunar infarcts), cerebral hemorrhage, brain tumors, epilepsy, severe traumatic brain injury, or prior brain surgery;

Secondary white matter hyperintensities due to inflammatory, toxic causes and so on;

Contraindications to MRI.

Trial design

Treatments tested in this trial

  • No intervention

Treatment groups

500 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators